600415:SSEZhejiang China Commodities City Group Co. Ltd. Class A Analysis
Data as of 2026-03-15 - not real-time
CN¥13.85
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at CNY 13.85, well below its 20‑day SMA of ~14.6, 50‑day SMA of ~15.8 and 200‑day SMA of ~18.0, signaling a bearish technical backdrop. However, the RSI sits near 31, indicating oversold conditions, and the MACD histogram has turned marginally positive, suggesting a possible short‑term rebound toward the identified support around CNY 13.74. Volatility remains elevated at over 25% for the past month, yet the beta is low at 0.26, meaning market swings have limited impact on the share. Fundamentally, the company posts strong profitability – operating margin above 38% and ROE of 20% – and generates robust cash flow, with free cash flow exceeding CNY 11 bn. The DCF‑derived fair value of roughly CNY 78.5 implies a massive valuation gap, while the dividend yield of 2.38% and a payout ratio under 45% point to sustainable shareholder returns.
Given the deep discount to intrinsic value, solid balance sheet, and reliable dividend, the stock presents a compelling value case despite short‑term technical weakness. The consumer‑cyclical nature of its footwear & accessories segment adds medium‑term sector risk, and regulatory oversight in China introduces a moderate regulatory head‑wind, but the low beta and strong cash generation mitigate overall risk. Investors should weigh the upside potential against the current bearish trend, with a bias toward buying on dips and holding for the anticipated mean‑reversion and dividend income.
Given the deep discount to intrinsic value, solid balance sheet, and reliable dividend, the stock presents a compelling value case despite short‑term technical weakness. The consumer‑cyclical nature of its footwear & accessories segment adds medium‑term sector risk, and regulatory oversight in China introduces a moderate regulatory head‑wind, but the low beta and strong cash generation mitigate overall risk. Investors should weigh the upside potential against the current bearish trend, with a bias toward buying on dips and holding for the anticipated mean‑reversion and dividend income.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI indicating potential bounce
- Price near defined support level
- Low systematic beta limiting market‑wide shocks
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap versus DCF fair value
- Strong cash flow and sustainable dividend yield
- Improving technical signal from bullish MACD histogram
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and high operating margins supporting earnings growth
- Long‑term upside from digital trading platform expansion
- Dividend sustainability providing steady income over time
Key Metrics & Analysis
Financial Health
Revenue Growth39.00%
Profit Margin23.11%
P/E Ratio18.2
ROE20.01%
ROA7.82%
Debt/Equity20.80
P/B Ratio3.4
Op. Cash FlowCN¥13.6B
Free Cash FlowCN¥11.5B
Technical Analysis
TrendBearish
RSI31.0
SupportCN¥13.74
ResistanceCN¥15.45
MA 20CN¥14.59
MA 50CN¥15.75
MA 200CN¥17.96
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥78.53
GradeUndervalued
TypeValue
Dividend Yield2.38%
Risk Assessment
Beta0.26
Volatility25.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.